Acadian Asset Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,393	Closed	-$118K	–	1676
2021 Q3	$118K	Sell	2,393 -6,896	-74%	-$340K	﹤0.01%	1413
2021 Q2	$529K	Buy	+9,289	New	+$529K	﹤0.01%	1135
2018 Q4	–	Sell	-818	Closed	-$47K	–	1720
2018 Q3	$47K	Buy	+818	New	+$47K	﹤0.01%	1374